This randomized control trial is to test the efficacy of a stepped-care "adaptive" Antiretroviral Therapy (ART) adherence intervention ("Positive STEPS") for HIV infected adolescents and young adults, ages 16 to 29. Stepped care is a healthcare delivery model in which the least resource intensive part of an intervention is delivered first, and only those who do not improve then receive the high intensity, more resource intensive part of an intervention.
HIV infected adolescents and young adults will be recruited from Providence, Rhode Island, Boston, Massachusetts and Chicago, Illinois. Participants will be equally randomized to: 1. "Positive STEPS" - a stepped care, adherence intervention with integrated technology (2-way daily text messaging aimed at improving ART adherence). If text messaging is not sufficient to overcome the barriers to ART adherence;these individuals will then also receive the more intensive component based on general principles of cognitive-behavioral therapy. 2. Standard of Care comparison group including a brief adherence educational session. This will consist of a review of medications and recommended dosing (i.e., to understand regimen), adherence expectations, toxicity expectations and medication misperceptions.The participant will then view a 20-minute animated tutorial which explains the importance of adherence to antiretroviral medication effectiveness.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
123
Step 1: 2 way SMS text messages; Step 2: Five in-person, counseling sessions. Each counseling session will last approximately 50 minutes.
UCLA Center for LGBTQ+ Advocacy, Research & Health
Los Angeles, California, United States
Lurie Childrens Hospital
Chicago, Illinois, United States
Fenway Health Institute
Boston, Massachusetts, United States
Brown University School of Public Health
Providence, Rhode Island, United States
Reduced HIV Viral Load
Blood specimen collection tested for HIV Viral Load
Time frame: Baseline, 4 month, 8 month, 12 month
ART Medication Level in Hair Sample
Collection of hair sample to measure level of ART
Time frame: Baseline, 4 month, 8 month, 12 month
Daily ART adherence
Monitoring of Wisepill device for electronic adherence data
Time frame: 4 month, 8 month, 12 month
Daily ART Adherence
Self report via research assessment
Time frame: Baseline, 4 month, 8 month, 12 month
Reduced HIV Symptoms
Medical record review for increase or decrease in symptoms associated with HIV
Time frame: Baseline, 4 month, 8 month, 12 month
Engagement in HIV Care
Number of kept versus number of scheduled visits verified by medical record
Time frame: Baseline, 4 month, 8 month, 12 month
Medication changes to ART
Verified by medical record
Time frame: Baseline, 4 month, 8 month, 12 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.